UK markets closed

Syndax Pharmaceuticals, Inc. (SNDX)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
21.55-0.42 (-1.91%)
As of 12:04PM EDT. Market open.
Currency in USD
Earnings estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts11111212
Avg. Estimate-0.96-1.01-3.66-2.89
Low estimate-1.11-1.14-4.03-3.69
High estimate-0.88-0.64-3.12-1.17
Year ago EPS-0.64-0.73-2.98-3.66
Revenue estimateCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
No. of analysts771212
Avg. EstimateN/A8.23M30.81M112.18M
Low estimateN/AN/A5.98M68.1M
High estimateN/A30M81.99M278.08M
Year ago salesN/AN/AN/A30.81M
Sales growth (year/est)N/AN/AN/A264.10%
Earnings history29/06/202329/09/202330/12/202330/03/2024
Est. EPS-0.73-0.79-0.99-0.98
Actual EPS-0.64-0.73-1-0.85
Difference0.090.06-0.010.13
Surprise %12.30%7.60%-1.00%13.30%
EPS trendCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Current estimate-0.96-1.01-3.66-2.89
7 days ago-1.04-1.02-3.86-2.92
30 days ago-1.04-1.02-3.86-2.9
60 days ago-1.04-1.02-3.87-2.89
90 days ago-0.88-0.87-3.18-2.43
EPS revisionsCurrent qtr. (Jun 2024)Next qtr. (Sep 2024)Current year (2024)Next year (2025)
Up last 7 days6385
Up last 30 days6385
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/A314
Growth estimatesSNDXIndustrySector(s)S&P 500
Current qtr.-50.00%N/AN/AN/A
Next qtr.-38.40%N/AN/AN/A
Current year-22.80%N/AN/AN/A
Next year21.00%N/AN/AN/A
Next 5 years (per annum)N/AN/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A